title: Ezetimibe-induced acute pancreatitis.
abstract: Ezetimibe is a lipid-lowering agent that inhibits the intestinal absorption of cholesterol and other related phytosterols. It is used alone or in combination with other lipid-lowering agents in the treatment of various forms of hypercholesterolemia. Since its FDA approval in 2002, there are no known citations of ezetimibe-induced pancreatitis.
authors: Mercy Fitzgerald Hospital, Darby, PA, USA. iahmadmd@yahoo.com
authors: Imran
authors: I
authors: Ahmad
authors: Edward
authors: E
authors: Ruby
authors: Harris
authors: H
authors: Usman
authors: Mateen
authors: M
authors: Hotiana
authors: Mehnaz
authors: M
authors: Hussain
authors: Fahd
authors: F
authors: Rahman
mesh_terms: D000924:Anticholesteremic Agents / Q000009:adverse effects* / Q000627:therapeutic use; D001384:Azetidines / Q000009:adverse effects* / Q000627:therapeutic use; D003937:Diagnosis, Differential; D050171:Dyslipidemias / Q000188:drug therapy; D000069438:Ezetimibe; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D008049:Lipase / Q000097:blood; D008875:Middle Aged; D019283:Pancreatitis, Acute Necrotizing / Q000139:chemically induced* / Q000175:diagnosis / Q000201:enzymology
chemical_list: D000924:Anticholesteremic Agents; D001384:Azetidines; D008049:Lipase; D000069438:Ezetimibe